ProCE Banner Activity

ExpressPoints: EGFR-Mutant Advanced NSCLC: Global Insights on Testing and Treatment Planning

Slideset Download
Download this living summary slideset of key takeaways from a live CCO Webinar featuring the latest clinical data informing optimal treatment of patients with EGFR-mutant advanced NSCLC, including guidance on testing for EGFR mutations and new data from ASCO 2021.

Released: June 23, 2021

Expiration: June 22, 2022

Share

Faculty

Edward S. Kim

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Tetsuya Mitsudomi

Tetsuya Mitsudomi, MD

Professor
Department of Thoracic Surgery
Kindai University Faculty of Medicine
Osaka-Sayama, Japan

Luis Paz-Ares

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Head of the Lung Cancer Unit
CNIO (Spanish National Cancer Research Center)
Madrid, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Edward S. Kim, MD

Chief, Section of Head and Neck Medical Oncology
Associate Professor, Thoracic/Head and Neck Medical Oncology
University of Texas M. D. Anderson Cancer Center
Houston, Texas

Tetsuya Mitsudomi, MD

Professor
Department of Thoracic Surgery
Kindai University Faculty of Medicine
Osaka-Sayama, Japan

Luis Paz-Ares, MD, PhD

Chair of the Medical Oncology Department
Hospital Universitario 12 de Octubre
Associate Professor
Universidad Complutense de Madrid
Head of the Lung Cancer Unit
CNIO (Spanish National Cancer Research Center)
Madrid, Spain